Literature DB >> 1702910

Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro.

M Wasik1, A Gorski, B Stepien-Sopniewska, Z Lagodzinski.   

Abstract

The effect of FK506 and cyclosporine on NK and ADCC activity was evaluated. Cytotoxic cells mediating both activities are resistant to FK506. In contrast, preincubation of ADCC and NK effectors with cyclosporine decreases their cytotoxic potential, while adding the drug to the assays is without effect.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1702910     DOI： 10.1097/00007890-199101000-00045

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  6 in total

1.  Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.

Authors:  Olivier Morteau; Samkeliso Blundell; Aron Chakera; Sophia Bennett; Charita M Christou; Philip D Mason; Richard J Cornall; Christopher A O'Callaghan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

2.  Calcineurin-dependent lytic granule exocytosis in NK-92 natural killer cells.

Authors:  Arun T Pores-Fernando; Surabhi Gaur; Michelle Y Doyon; Adam Zweifach
Journal:  Cell Immunol       Date:  2008-08-30       Impact factor: 4.868

Review 3.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury.

Authors:  Daniel R Calabrese; Emily Aminian; Benat Mallavia; Fengchun Liu; Simon J Cleary; Oscar A Aguilar; Ping Wang; Jonathan P Singer; Steven R Hays; Jeffrey A Golden; Jasleen Kukreja; Daniel Dugger; Mary Nakamura; Lewis L Lanier; Mark R Looney; John R Greenland
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

5.  Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.

Authors:  Aislin C Meehan; Nicole A Mifsud; Thi H O Nguyen; Bronwyn J Levvey; Greg I Snell; Tom C Kotsimbos; Glen P Westall
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

6.  Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.

Authors:  Heiner Zimmermann; Theresa Weiland; Jamie P Nourse; Maher K Gandhi; Petra Reinke; Ruth Neuhaus; Mohsen Karbasiyan; Barbara Gärtner; Ioannis Anagnostopoulos; Hanno Riess; Ralf U Trappe; Stephan Oertel
Journal:  J Immunol Res       Date:  2014-02-10       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.